Deerfield Beach, FL, March 10, 2016 -- Zion Research has published a new report titled “Influenza (H1N1 Vaccines and Others) Industry by Product (Influenza Vaccines and Influenza Drugs): Global Market Perspective, Comprehensive Analysis and Forecast, 2014 - 2020.” According to the report, the global influenza market was valued at USD 4.27 billion in 2014 and is expected to reach at USD 6.87 billion by 2020, growing at a CAGR of 8.33% between 2015 and 2020.
Browse the full "Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 - 2020" report at http://www.marketresearchstore.com/report/influenza-market-by-product-36077
Influenza infection can affect throat, nose as well as lungs. It’s a contagious disease in which three types of viruses includes namely as influenza type A, influenza type B, influenza type C. Seasonal, pandemic and zoonotic or variant are the types of influenza. Trivalent flu vaccines are made to protect against influenza viruses.
Increasing awareness regarding influenza is one of the major driving factors for global influenza market. Moreover, world health organization (WHO) has also come up with a global action plan for influenza vaccination across the globe. However, influenza market is expected to face major challenge from antigenic drift of influenza viruses. Influenza virus continuously evolves at a rapid pace. Additionally, lack of cold storage facilities presents major challenge for the growth of influenza market.
Browse Market Tables and 39 Figures spread through 105 Pages and an in-depth TOC on “Influenza Market - Global Size, Shares, Trends, Segment & Forecast to 2020”
Get Sample Research Report at http://www.marketresearchstore.com/report/influenza-market-by-product-36077#RequestSample
H1N1 vaccines accounts for major chunk of influenza market with around 79% share of the total market in 2014. Influenza market is also segmented based on drugs and vaccines. Vaccines dominated the influenza market with over 80% share of the market in 2014. It is also expected to be the fastest growing market segment during the forecast period. On the basis of regions, global influenza market has been segmented as Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. Americas dominated the global market with around 60% share of the global market in 2014. Americas was followed by EMEA and Asia Pacific respectively.
Some of the key industry participants in global influenza market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others. Global influenza market is led by top five companies including AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur. This five companies accounts for over two third shares of the global market.
Related Published Reports:
- Wearable Medical Devices Market: http://www.marketresearchstore.com/report/wearable-medical-devices-market-z38120
- Home Healthcare Market: http://www.marketresearchstore.com/report/global-home-healthcare-market-z38958
- Hyaluronic Acid Market: http://www.marketresearchstore.com/report/hyaluronic-acid-market-z47488
This report segments the global influenza market as follows:
Influenza Market - Product Segment Analysis
- Influenza Vaccines
- Influenza Drugs
Influenza Market – Regional Analysis
- Americas
- EMEA (Europe, Middle East and Africa)
- Asia Pacific
Browse Press Release: http://www.marketresearchstore.com/news/global-influenza-market-is-expected-to-reach-usd-64
About Us
Market Research Store is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Market Research Store experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each Market Research Store syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.
Follow Us LinkedIn: http://www.linkedin.com/company/market-research-store
Follow Us Twitter: https://twitter.com/marketrstore
Blog: http://www.syndicatemarketresearch.com/
Contact US: Joel John 3422 SW 15 Street, Suit #8138 Deerfield Beach, Florida 33442, USA Toll Free: +1-855-465-4651 (USA-CANADA) Tel: +1-386-310-3803 Email: [email protected] Website: http://www.marketresearchstore.com/


OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 



